Leuprolide Legal Status: Approval, Research Use, and Regulatory Notes
FDA-approved prescription medication. Multiple formulations and brand names (Lupron, Eligard, Fensolvi). Not a controlled substance.
Direct Answer
Leuprolide (Lupron) is FDA-approved for prostate cancer, endometriosis, uterine fibroids, and precocious puberty - one of the broadest indication profiles of any peptide drug in this library. With 40+ years of clinical use and extensive Phase 3 data across multiple indications, it is the reference GnRH agonist. A highly validated compound by any standard.
- Evidence grade
- Level A
- Research status
- FDA Approved
- Category
- Sexual Health
- Best for
- Prostate cancer hormone therapy, endometriosis, uterine fibroids, precocious puberty, GnRH agonist reference compound
Legal and Regulatory Status
FDA-approved prescription medication. Multiple formulations and brand names (Lupron, Eligard, Fensolvi). Not a controlled substance.
Approval Stage
Leuprolide is listed as FDA Approved. Approved uses, if any, are indication-specific and do not automatically apply to other claims.
Compliance Notes
- Tumor flare in first 1-2 weeks - anti-androgen cover recommended for prostate cancer
- Bone density monitoring recommended with use >6 months
- Increased cardiovascular and metabolic risk with long-term ADT
- Rare reports of pituitary apoplexy in patients with pituitary adenomas
- QT prolongation risk
Evidence Page
For the complete evidence review, see the main Leuprolide guide linked below.
Evidence Snapshot
| Evidence grade | Level A |
|---|---|
| Research status | FDA Approved |
| Best supported outcomes | Advanced Prostate Cancer (Level A), Endometriosis Management (Level A), Central Precocious Puberty (Level A), and Uterine Fibroid Shrinkage (Level A) |
| Primary citation count | 3 |
| Last reviewed | 2026-04-04 |
Related Guides
How to Cite This Page
ExaminePeptides. "Leuprolide Legal Status: Approval, Research Use, and Regulatory Notes." Last reviewed 2026-04-04. https://examinepeptides.com/answers/leuprolide-legal-status/
This static answer page is built for fast indexing and direct citation. It summarizes the matching full evidence review and links back to primary sources where the source database includes them.